-
Australia Jobless Rate Rises To 5.4% In December
Thursday, January 17, 2013 - 3:51amAustralia's jobless rate climbed to 5.4% in December, according to the Australian Bureau of Statistics. Australia's jobless rate reached 5.3% in November. However, economists were expecting rate to reach 5.4% in the month of December. The number of employed in Australia declined 5,500 to 11.5...
Read More >>
Australia's jobless rate
Benzinga Professional
- 9:02 AM Caterpillar Announces April North American Three-Month Machine Retail Sales Down 18%, Down 9%
- 9:01 AM Wells Fargo Initiates Coverage on TMHC at Outperform
- 9:01 AM OSI Systems Issues Update on TSA Show-Cause Letter Related to Rapiscan, Says Unit Notified DHS Issued Notice of Proposed Debarment
- 8:59 AM Credit Suisse Initiates Coverage on TMHC at Outperform, Announces $30 PT
- 8:59 AM Shares of Peregrine Pharma to Resume Trade at 9:15AM EDT
- 8:59 AM Longbow Research Downgrades Dunkin' Brands Group, Inc. to Neutral, Removes $45.00 PT
- 8:56 AM Ensco Holders Elect Two New Directors, Authorize $2B Buyback Plan
- 8:56 AM UPDATE: Ariad CEO Says Expecting Mid-2014 Japanese Regulatory Submission for Iclusig, Sees Iclusig Epic Trial Full Patient Enrollment by End of 2013, Sees Q3 Interim Analysis for Trial
- 8:54 AM Ariad Pharma CEO Speaking at UBS Conference: Expecting 'Strong Launch of Iclusig in US' in 2013, Sees Q3 AP26113 Pivotal Trial in Parallel with Phase 2
- 08:48 AM Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer
- 8:48 AM OSI Systems Halted News Pending
- 8:48 AM Peregrine Pharma Announces Deal with FDA on Phase II Study Deesign for Bavituximab
- 8:41 AM Miller Energy Resources Says Will Begin Drilling Sword #1 Well
- 8:41 AM Peregrine Pharma Shares Halted News PEnding
- 8:40 AM Iberia Capital Upgrades James River Coal Company to Outperform, Announces $5.00 PT
Brain Trust
MORE FROM InvestorsObserver
MORE FROM Michael Prus
- UPDATE: Stifel Nicolaus Downgrades Range Resources to Hold on Valuation, More Cautious Outlook
- UPDATE: Stifel Nicolaus Downgrades Kansas City Southern to Sell on Valuation
- UPDATE: Stifel Nicolaus Downgrades Capella Education to Hold on Recent Strength, Resulting Valuations
- UPDATE: Goldman Sachs Downgrades Thoratec Accounting on Challenged Outer Year Growth
- UPDATE: Oppenheimer Downgrades Lowe's Companies to Perform on Uncertainty Ahead
- Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer
- WellCare Medicare Advantage Members Now Covered at Walgreens Take Care Clinics
- UPDATE: Nomura Downgrades SanDisk Corporation to Neutral as Stock Approaches Target
- UPDATE: Deutsche Bank Upgrades Priceline.com to Buy on Multiple Positive Factors
- UPDATE: Jefferies Downgrades Bed Bath & Beyond to Hold on Valuation
- The 5 Can't-Miss Apple Stories from the Past Week
- Earnings Expectations for the Week of May 20
- U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying
- Benzinga's M&A Chatter for Friday May 17, 2013
- Barron's Recap: Cues from Cooperman
- Campbell Soup Earnings Preview: Double-Digit Revenue Growth Expected
- Can You Think of 9 Companies with Stellar Customer Service?
- Presidential Visit Puts Myanmar Investment Theme in Spotlight
- Benzinga Market Primer: Monday, May 20
- A Look Ahead: This Week's ETFs to Watch